Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine
✍ Scribed by J. Martinuč Porobič; T. Avčin; B. Božič; M. Kuhar; S. Čučnik; M. Zupančič; K. Prosenc; T. Kveder; B. Rozman
- Book ID
- 110090455
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 125 KB
- Volume
- 142
- Category
- Article
- ISSN
- 0009-9104
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Patients after orthotopic liver transplantation (OLT) due to hepatitis B virus (HBV)-related disease are at risk of endogenous hepatitis B reinfection and may receive life long prophylaxis with hepatitis B hyperimmunoglobulin (HBIG). In a previous study 16 of 20 OLT patients were immunized successfu
A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs